SGRY
|
Surgery Partners, Inc.
|
US
|
NASDAQ
|
SNY
|
Sanofi
|
US
|
NASDAQ
|
SONX
|
Sonendo, Inc.
|
US
|
NYSE
|
SPRC
|
SciSparc Ltd.
|
US
|
NASDAQ
|
TBPH
|
Theravance Biopharma, Inc.
|
US
|
NASDAQ
|
TEVA
|
Teva Pharmaceutical Industries
|
US
|
NYSE
|
TIVC
|
Tivic Health Systems, Inc.
|
US
|
NASDAQ
|
TRVN
|
Trevena, Inc.
|
US
|
NASDAQ
|
VRPX
|
Virpax Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
XENE
|
Xenon Pharmaceuticals Inc.
|
US
|
NASDAQ
|
ZYNE
|
Zynerba Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
ZYXI
|
Zynex, Inc.
|
US
|
NASDAQ
|
ADVT
|
Advantis Corporation
|
US
|
OTC
|
ADYX
|
Adynxx Inc
|
US
|
OTC
|
AMEUF
|
Admedus
|
US
|
OTC
|
AMPED
|
Ampio Pharmaceuticals
|
US
|
OTC
|
AOXG
|
Aoxing Pharmaceutical Company Inc.
|
US
|
OTC
|
ATBPF
|
Antibe Therapeutics
|
US
|
OTC
|
ATRX
|
Adhera Therapeutics Inc.
|
US
|
OTC
|
AXIM
|
Axim Biotechnologies
|
US
|
OTC
|